未登录

M

Meili Ge

national clinical research center for blood diseases

H指数:16

被引数:978

浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Somatic mutations and the efficacy of immunosuppressive therapy in severe/very severe aplastic anemia and transfusion-dependent nonsevere aplastic anemia

体细胞突变和免疫抑制疗法在重度/极重度再生障碍性贫血及输血依赖性非重度再生障碍性贫血中的疗效

Annals of Hematology

IF2.4

2025-08-070

OA

DICER1 Mutations Exhibit a Distinctive Immune Characteristics With Enhanced Immune Checkpoint Inhibitor Efficacy in Uterine Corpus Endometrial Carcinoma

DICER1基因突变在子宫体子宫内膜癌中表现出独特的免疫特征，并增强了免疫检查点抑制剂的疗效。

Clinical Oncology

IF3

2025-05-300

PRE

IFN-γ Synergizes with TNF-α to Induce RIPK1-Independent Necroptosis of Mesenchymal Stem/Stromal Cells

IFN-γ与TNF-α协同作用，诱导间充质干细胞/基质细胞发生RIPK1非依赖性坏死性凋亡。

Advanced Biology

IF2.6

2025-05-280

PRE

Targeting interleukin-2-inducible T cell kinase ameliorates immune-mediated aplastic anemia

靶向白细胞介素-2可诱导的T细胞激酶可改善免疫介导的再生障碍性贫血

CANCER IMMUNOLOGY IMMUNOTHERAPY

IF5.1

2025-04-290

OA

Thrombopoietin Receptor Agonist Added to Standard Immunosuppressive Therapy for Hepatitis-Associated Aplastic Anemia

添加血小板生成素受体激动剂至肝炎相关性再生障碍性贫血的标准免疫抑制治疗中

IF23.1

2024-11-050

PRE

The Therapeutic Effect of Myeloid-Suppressor Cells Induced By Umbilical Cord Blood CD34+cells in Mice with Aplastic Anemia

脐带血CD34+细胞诱导的髓系抑制细胞对小鼠再生障碍性贫血的疗效

IF23.1

2024-11-050

PRE

Anti-CD38 Monoclonal Antibody Is a Salvage Regimen in Relapsed/Refractory Aplastic Anemia

抗CD38单克隆抗体是复发/难治性再生障碍性贫血的挽救治疗方案

IF23.1

2024-11-050

PRE

Cyclophosphamide Combined with Standard Immunosuppressive Therapy Improves Early Response Outcomes in Severe Aplastic Anemia

环磷酰胺联合标准免疫抑制疗法可改善重型再生障碍性贫血的早期反应结局

IF23.1

2024-11-050

PRE

Tyrosine phosphorylation of both STAT5A and STAT5B is necessary for maximal IL-2 signaling and T cell proliferation

NATURE COMMUNICATIONS

IF15.7

2024-08-270

OAAI

Distinct use of super-enhancer elements controls cell type-specific CD25 transcription and function

SCIENCE IMMUNOLOGY

IF16.3

2023-11-242

OA

Impaired immunosuppressive effect of bone marrow mesenchymal stem cell-derived exosomes on T cells in aplastic anemia

STEM CELL RESEARCH & THERAPY

IF7.3

2023-10-040

OAAI

Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-01-304

OAAI

Natural killer cells in peripheral blood at diagnosis predict response to immunosuppressive therapy in severe aplastic anemia

CLINICAL AND EXPERIMENTAL MEDICINE

IF3.5

2022-10-163

PRE

Cluster analysis of lymphocyte subset from peripheral blood in newly diagnosed idiopathic aplastic anaemia patients

ANNALS OF MEDICINE

IF4.3

2022-09-066

OAAI

Levamisole Suppresses CD4+ T-Cell Proliferation and Antigen-Presenting Cell Activation in Aplastic Anemia by Regulating the JAK/STAT and TLR Signaling Pathways

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-07-1412

OAAI

Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia

IF7.9

2022-06-2310

OAAI

Abstract Book for the 27th Congress of the European Hematology Association

IF14.6

2022-06-230

OAAI

Leptin-mediated proinflammatory bone marrow environment in acquired aplastic anemia

IF3.7

2022-04-012

PRE

Long-term follow-up of a novel immunosuppressive strategy of cyclosporine alternatively combined with levamisole for severe aplastic anemia

环孢素联合左旋咪唑治疗重型再生障碍性贫血的新免疫抑制策略的长期随访

ANNALS OF HEMATOLOGY

IF2.4

2020-06-295

PREAI

Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemia

STEM CELL RESEARCH & THERAPY

IF7.3

2020-02-1359

OAAI